Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 4
2004 5
2005 5
2006 4
2011 3
2012 4
2013 3
2014 5
2015 7
2016 13
2017 11
2018 10
2019 3
2020 7
2021 10
2022 7
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Results by year

Filters applied: . Clear all
Page 1
Telemedical cardiac risk assessment by implantable cardiac monitors in patients after myocardial infarction with autonomic dysfunction (SMART-MI-DZHK9): a prospective investigator-initiated, randomised, multicentre, open-label, diagnostic trial.
Bauer A, Sappler N, von Stülpnagel L, Klemm M, Schreinlechner M, Wenner F, Schier J, Al Tawil A, Dolejsi T, Krasniqi A, Eiffener E, Bongarth C, Stühlinger M, Huemer M, Gori T, Wakili R, Sahin R, Schwinger R, Lutz M, Luik A, Gessler N, Clemmensen P, Linke A, Maier LS, Hinterseer M, Busch MC, Blaschke F, Sack S, Lennerz C, Licka M, Tilz RR, Ukena C, Ehrlich JR, Zabel M, Schmidt G, Mansmann U, Kääb S, Rizas KD, Massberg S; SMART-MI-DZHK9 investigators. Bauer A, et al. Among authors: blaschke f. Lancet Digit Health. 2022 Feb;4(2):e105-e116. doi: 10.1016/S2589-7500(21)00253-3. Lancet Digit Health. 2022. PMID: 35090674 Free article. Clinical Trial.
Left ventricular dysfunction in heart failure with preserved ejection fraction-molecular mechanisms and impact on right ventricular function.
Heinzel FR, Hegemann N, Hohendanner F, Primessnig U, Grune J, Blaschke F, de Boer RA, Pieske B, Schiattarella GG, Kuebler WM. Heinzel FR, et al. Among authors: blaschke f. Cardiovasc Diagn Ther. 2020 Oct;10(5):1541-1560. doi: 10.21037/cdt-20-477. Cardiovasc Diagn Ther. 2020. PMID: 33224773 Free PMC article. Review.
Wearable cardioverter-defibrillator: friend or foe in suspected myocarditis?
Blaschke F, Lacour P, Dang PL, Parwani AS, Hohendanner F, Walter T, Klingel K, Kühl U, Heinzel FR, Sherif M, Boldt LH, Pieske B, Tschöpe C. Blaschke F, et al. ESC Heart Fail. 2021 Aug;8(4):2591-2596. doi: 10.1002/ehf2.13340. Epub 2021 May 1. ESC Heart Fail. 2021. PMID: 33932118 Free PMC article.
Vascular effects of TZDs: new implications.
Blaschke F, Spanheimer R, Khan M, Law RE. Blaschke F, et al. Vascul Pharmacol. 2006 Jul;45(1):3-18. doi: 10.1016/j.vph.2005.11.009. Epub 2006 Jun 5. Vascul Pharmacol. 2006. PMID: 16740417 Review.
COVID19-associated cardiomyocyte dysfunction, arrhythmias and the effect of Canakinumab.
Dimai S, Semmler L, Prabhu A, Stachelscheid H, Huettemeister J, Klaucke SC, Lacour P, Blaschke F, Kruse J, Parwani A, Boldt LH, Bullinger L, Pieske BM, Heinzel FR, Hohendanner F. Dimai S, et al. Among authors: blaschke f. PLoS One. 2021 Aug 19;16(8):e0255976. doi: 10.1371/journal.pone.0255976. eCollection 2021. PLoS One. 2021. PMID: 34411149 Free PMC article.
93 results